Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Block Admission Update

30 May 2024 13:46

RNS Number : 5058Q
Bowleven plc
30 May 2024
 

 

 

 

30 May 2024

 

 

Bowleven plc ('Bowleven')

Block Admission Update

 

Bowleven plc ("Bowleven" or the "Company") announces, in connection with its block admission originally announced on 8 May 2018, that all share options issued pursuant to its Approved CSOP Scheme and Schedule 4 CSOP Scheme, have now either been exercised or lapsed. As such, the Company's block admission in respect of a residual amount of 659,526 ordinary shares of 0.1 pence each ("Ordinary Shares") will be cancelled, with no further Ordinary Shares having been issued since its block admission return released on 9 May 2024.

 

The Company's issued share capital as at today remains unchanged with a total of 1,897,772,933 Ordinary Shares in issue. The Company holds 11,913,609 Ordinary Shares in treasury. The total number of voting rights in the Company is therefore 1,885,859,324. This number should be used by shareholders as the denominator for the calculation of notifiable interests in, or changes to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

ENQUIRIES

 

For further information, please contact:

 

Bowleven plc

Eli Chahin, Chief Executive

00 44 20 3327 0150

Camarco (Financial PR)

Owen Roberts

00 44 20 3757 4980

Hugo Liddy

Shore Capital (NOMAD and Broker)

Daniel Bush

Rachel Goldstein

00 44 20 7408 4090

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSFESIIVIS
Date   Source Headline
24th Sep 20247:00 amRNSCancellation - BowLeven Plc
20th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20246:00 pmRNSBowLeven
12th Sep 202410:11 amRNSResult of Exit Opportunity
28th Aug 20242:25 pmRNSResult of GM
9th Aug 20247:00 amRNSCancellation, Exit Opportunity & Notice of GM
22nd Jul 20247:00 amRNSBoard Appointment
30th May 20241:46 pmRNSBlock Admission Update
9th May 20249:52 amRNSBlock Admission Six Monthly Return
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.